Dr. Yasmin Hurd is the Director of the Addiction Institute within the Mount Sinai Behavioral Health System as well as the Ward Coleman Chair of Translational Neuroscience and Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai in New York. Dr. Hurd is an internationally renowned neuroscientist whose translational research examines the neurobiology of drug abuse and related psychiatric disorders. Her research exploring the neurobiological effects of cannabis and heroin has significantly shaped the field. Using multidisciplinary research approaches, her research has provided unique insights into the impact of developmental cannabis exposure and epigenetic mechanisms underlying the drug’s protracted effects into adulthood and even across generations. Dr. Hurd’s basic science research is complemented by clinical laboratory investigations evaluating the therapeutic potential of novel science-based strategies for the treatment of opioid addiction and related psychiatric disorders. This includes pioneering studies with cannabidiol for the treatment of opioid use disorder. Based on these high impact accomplishments and her advocacy of drug addiction education and health, Dr. Hurd was inducted into the National Academy of Medicine that complements other honors she has received in the field including the Mika Salpeter Lifetime Achievement Award from the Society for Neuroscience.